We are live on ! Find out more
SRCL

Stericycle Inc

Delisted

SRCL was delisted on the 1st of November, 2024.

502 hedge funds and large institutions have $4.96B invested in Stericycle Inc in 2018 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 174 increasing their positions, 175 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

1% less repeat investments, than reductions

Existing positions increased: 174 | Existing positions reduced: 175

3% less funds holding

Funds holding: 520502 (-18)

10% less capital invested

Capital invested by funds: $5.5B → $4.96B (-$539M)

14% less first-time investments, than exits

New positions opened: 68 | Existing positions closed: 79

33% less call options, than puts

Call options by funds: $16.3M | Put options by funds: $24.4M

Holders
502
Holders Change
-18
Holders Change %
-3.46%
% of All Funds
11.51%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.11%
New
68
Increased
174
Reduced
175
Closed
79
Calls
$16.3M
Puts
$24.4M
Net Calls
-$8.03M
Net Calls Change
+$3.48M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$506M +$6.62M +97,732 +1%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$440M -$63.8M -942,887 -11%
BlackRock
3
BlackRock
New York
$307M -$13.4M -197,938 -4%
Invesco
4
Invesco
Georgia
$192M +$90M +1,329,317 +68%
State Street
5
State Street
Massachusetts
$191M -$4.92M -72,687 -2%
Wells Fargo
6
Wells Fargo
California
$177M +$13.2M +194,423 +7%
Baillie Gifford & Co
7
Baillie Gifford & Co
United Kingdom
$150M -$1.56M -23,064 -0.9%
CCP
8
Clarkston Capital Partners
Michigan
$144M +$31.1M +459,950 +23%
FC
9
Fairpointe Capital
Illinois
$143M +$7.93M +117,172 +5%
TSW
10
Thompson Siegel & Walmsley
Virginia
$113M +$26M +383,878 +25%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$97.1M +$2.77M +40,924 +3%
UBS AM
12
UBS AM
Illinois
$92.2M +$90.8M +1,341,620 +576%
Norges Bank
13
Norges Bank
Norway
$86.4M +$17.6M +260,518 +21%
Jennison Associates
14
Jennison Associates
New York
$78.2M -$9.42M -139,115 -9%
CIP
15
Champlain Investment Partners
Vermont
$76.5M +$16.5M +244,095 +23%
AllianceBernstein
16
AllianceBernstein
Tennessee
$72.6M +$16.4M +242,704 +24%
Schroder Investment Management Group
17
Schroder Investment Management Group
United Kingdom
$72.2M +$20.6M +304,952 +33%
Goldman Sachs
18
Goldman Sachs
New York
$67.9M +$24.1M +355,678 +44%
GTP
19
Global Thematic Partners
New York
$67.7M +$2.59M +38,204 +3%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$60.3M +$5.73M +84,703 +9%
FWIA
21
Fort Washington Investment Advisors
Ohio
$55.8M +$378K +5,589 +0.6%
Northern Trust
22
Northern Trust
Illinois
$55.5M -$878K -12,977 -1%
ClearBridge Investments
23
ClearBridge Investments
New York
$52.5M +$2.67M +39,471 +5%
CS
24
Credit Suisse
Switzerland
$50M +$8.91M +131,602 +18%
MIP
25
Mondrian Investment Partners
United Kingdom
$47.1M +$5.81M +85,788 +12%

SRCL Hedge Fund Activity: Q1 2018 in Review

502 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Stericycle Inc (SRCL) for Q1 2018, worth a combined $4.96B — down 9.8% from $5.5B a quarter earlier.

Sellers outnumbered buyers: 79 funds closed out of SRCL and 68 opened new positions — a net loss of 11 holders — while 175 trimmed existing stakes and 174 added.

The largest buyer was UBS AM, adding an estimated $90.8M. The largest seller was T. Rowe Price Associates, cutting an estimated $63.8M.

  • 502 institutional investors held Stericycle Inc (SRCL) as of Q1 2018, down from 520 in Q4 2017.
  • Funds reported $4.96B of Stericycle Inc stock for Q1 2018, down 9.8% quarter-over-quarter.
  • 68 funds opened new Stericycle Inc positions in Q1 2018 and 79 closed out, a net change of -11 holders.
  • The largest Stericycle Inc buyer in Q1 2018 was UBS AM, an estimated $90.8M added.
  • The largest Stericycle Inc seller in Q1 2018 was T. Rowe Price Associates, an estimated $63.8M sold.

Based on aggregated 13F filings for Q1 2018.